Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05045820 · ClinicalTrials.gov registry record · NA
Integrative Medicine in Pain Management in Sickle Cell Disease
A NA study of Pain and Sickle Cell Disease, sponsored by Indiana University.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05045820: Active NA study of Pain and Sickle Cell Disease, sponsored by Indiana University.
NCT05045820 is a NA study of Pain and Sickle Cell Disease that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 60 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05045820, a NA study of Pain and Sickle Cell Disease, is active but no longer recruiting, sponsored by Indiana University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed research is to determine the clinical efficacy and neurobiological mechanisms of acupuncture analgesia in patients with sickle cell disease.
Primary Outcome
Characteristics of functional brain activity will be studied using fMRI.
Conditions Studied
Interventions
- DEVICE needling acupuncture
- DEVICE laser acupuncture
Study Locations (1)
Indiana
- Indiana University School of Medicine - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-06-29 |
| Est. Completion | 2026-06-20 |
| Phase | NA |
What the registry record for NCT05045820 still lists
NCT05045820 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (80% lower).
The record links to 8 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which needling acupuncture is the first listed.
NCT05045820 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT05045820 about?
NCT05045820 is a clinical study titled "Integrative Medicine in Pain Management in Sickle Cell Disease". The proposed research is to determine the clinical efficacy and neurobiological mechanisms of acupuncture analgesia in patients with sickle cell disease.
What is the current status of trial NCT05045820?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-06-29. Estimated completion is 2026-06-20.
What conditions does trial NCT05045820 study?
This clinical trial studies the following conditions: Pain, Sickle Cell Disease, Magnetic Resonance Imaging, Acupuncture, Electroencephalography.
What interventions are being tested in trial NCT05045820?
The interventions under investigation include: needling acupuncture (DEVICE), laser acupuncture (DEVICE).
Who is sponsoring clinical trial NCT05045820?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05045820 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05045820's enrollment target sits among peer trials
60 224th of 374 higher than 134 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI